Business Context and Reporting Period
Company: La Rosa Holdings Corp.
Filing Type: Form 8-K (Current Report)
Report Date: July 14, 2025 (Earliest event reported)
Reporting Period: Events occurring July 14, 2025, and July 17, 2025.
Context: The filing reports the entry into material definitive agreements involving the exchange of warrants for common stock and the unregistered sale of equity securities for consulting services.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure transactions.
- Warrant Exercise Price: $0.135 per share (as adjusted).
- Shares Under Warrants: 1,851,852 shares per warrant.
- Shares Issued in Exchange: 75,000 shares per agreement.
- Shares Issued for Services: 50,000 shares.
Material Changes Versus Prior Period
The filing details specific capitalization changes rather than period-over-period financial performance comparisons.
- July 14, 2025: Entered an Exchange Agreement with a warrant holder. The holder surrendered a warrant for 1,851,852 shares in exchange for 75,000 newly issued shares of Common Stock.
- July 17, 2025: Entered a La Rosa Exchange Agreement with CEO Joseph La Rosa. Mr. La Rosa surrendered a warrant for 1,851,852 shares in exchange for 75,000 newly issued shares of Common Stock.
- July 14, 2025: Issued 50,000 unregistered shares of Common Stock to a consultant as compensation for services.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Board of Directors approved both exchange agreements. The transactions were executed to cancel outstanding warrants in exchange for a reduced number of common shares.
Regulatory Exemptions:
- The 150,000 shares issued in the warrant exchanges were issued pursuant to the exemption from registration requirements under Section 3(a)(9) of the Securities Act of 1933.
- The 50,000 shares issued to the consultant were issued in reliance on the exemption under Section 4(a)(2) of the Securities Act, as the issuance did not involve a public offering.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard disclosure that the descriptions of the agreements are subject to the full text of the documents attached as exhibits.
Key Facts for Investor Verification
- Dilution Impact: Verify the total number of shares outstanding post-transaction to assess the dilution effect of issuing 200,000 new shares (150,000 for warrants + 50,000 for services).
- Warrant Cancellation: Confirm that the two warrants covering a total of 3,703,704 potential shares have been fully cancelled and are no longer exercisable.
- Related Party Transaction: Review the terms of the exchange with CEO Joseph La Rosa to ensure the valuation of the 75,000 shares issued was fair relative to the warrant value surrendered.
- Consulting Agreement: Verify the terms of the consulting agreement that necessitated the issuance of 50,000 shares to a third party.
- Exhibit Review: Consult Exhibit 10.1 and Exhibit 10.2 for the complete legal terms of the exchange agreements, as the filing text notes the descriptions are not complete.